Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis

Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis: Prospective Observational Multicenter Study

The purpose of this study is to determine whether fecal calprotectin, fecal immunochemical test, and Rome III criteria for irritable bowel syndrome (IBS) can predict mucosal healing in patients with quiescent ulcerative colitis (UC).

Inclusion Criteria:

• Patients with ulcerative colitis who have no change of medication for at least 6 months
• Patients with ulcerative colitis who are in remission (Mayo score <3)
• Patients with ulcerative colitis who will undergo colonoscopy for surveillance or mucosal healing check-up

Exclusion Criteria:

• Patients who refuse to participate
• Patients who have a history of colectomy
• Patients who have instinal stricture or perforation